Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H6O3.C4H11N |
| Molecular Weight | 211.2576 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNCC.OC(=O)C1=C(O)C=CC=C1
InChI
InChIKey=JGMKRAUEFASZKH-UHFFFAOYSA-N
InChI=1S/C7H6O3.C4H11N/c8-6-4-2-1-3-5(6)7(9)10;1-3-5-4-2/h1-4,8H,(H,9,10);5H,3-4H2,1-2H3
| Molecular Formula | C4H11N |
| Molecular Weight | 73.1368 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C7H6O3 |
| Molecular Weight | 138.1207 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/uk/algesal-spc-11538.htmlCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14757512 | https://www.ncbi.nlm.nih.gov/pubmed/12356424
Sources: https://www.drugs.com/uk/algesal-spc-11538.html
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14757512 | https://www.ncbi.nlm.nih.gov/pubmed/12356424
Diethylamine salicylate is a salicylic acid salt, that is a cost-effective and simple, first-line treatment for rheumatic and minor musculoskeletal conditions including lumbago, fibrositis, sciatica, bruises, and strains. Salicylic acid directly and irreversibly inhibits the activity of both types of cyclo-oxygenases (COX-1 and COX-2) to decrease the formation of precursors of prostaglandins and thromboxanes from arachidonic acid. Salicylate's antirheumatic (nonsteroidal anti-inflammatory) actions are a result of its analgesic and anti-inflammatory mechanisms.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL230 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5284360 |
|||
Target ID: CHEMBL221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/5284360 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Algesal Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/uk/algesal-spc-11538.html
Topical As 10% cream: Apply 2-3 times/day.
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:32:35 GMT 2025
by
admin
on
Mon Mar 31 21:32:35 GMT 2025
|
| Record UNII |
5V7PT38BJU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4419-92-5
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | |||
|
162592
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB13573MIG
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | |||
|
DTXSID20963183
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | |||
|
224-586-4
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | |||
|
C026191
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | |||
|
9837223
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | |||
|
5V7PT38BJU
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY | |||
|
100000079574
Created by
admin on Mon Mar 31 21:32:35 GMT 2025 , Edited by admin on Mon Mar 31 21:32:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |